OmniAb (OABI) Research & Development (2022 - 2026)

OmniAb (OABI) has reported Research & Development for 5 consecutive years, with $9.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Research & Development fell 23.5% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $44.8 million (down 15.74% YoY), while the FY2025 annual figure was $47.8 million, down 13.35% from the prior year.
• Research & Development slipped to $9.6 million in Q1 2026 per OABI's latest filing, from $13.9 million in the prior quarter.
• Across five years, Research & Development topped out at $14.8 million in Q4 2023 and bottomed at $9.6 million in Q1 2026.
• Historically, Research & Development has averaged $12.8 million across 5 years, with a median of $13.3 million in 2024.
• Annual changes were most pronounced in 2023 — Research & Development advanced 27.73% — and 2026, when it declined 23.5%.
• OmniAb's Research & Development stood at $12.9 million in 2022, then grew by 14.3% to $14.8 million in 2023, then fell by 9.89% to $13.3 million in 2024, then climbed by 4.53% to $13.9 million in 2025, then sank by 30.69% to $9.6 million in 2026.
• Business Quant data shows OABI's Research & Development at $9.6 million in Q1 2026, $13.9 million in Q4 2025, and $10.4 million in Q3 2025.